Syneron Medical (ELOS) Q2 2014 Results - Earnings Call Webcast

Aug. 6.14 | About: Syneron Medical (ELOS)

Syneron Medical (NASDAQ:ELOS): Q2 EPS of $0.07 in-line. Revenue of $64.6M (+6.1% Y/Y) beats by $1.08M.

The following audio is from a conference call that will begin on August 06, 2014 at 08:30 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion.

If you would like to view a transcript of this call, please click here.